Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trastuzumab-conjugated liposomes for co-delivery of paclitaxel and anti-abcb1 siRNA in HER2-positive breast cancer: In vitro and in vivo evaluations

Published:2024-05 Issue: Volume:95 Page:105614
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Kumar Gautam,Mullick Prashansha,Andugulapati Sai Balaji^ORCID,Eedara Abhisheik Chowdary,Kumar Nitesh^ORCID,Mutalik Srinivas,Nandakumar Krishnadas,Chamallamudi Mallikarjuna Rao

Funder

All India Council for Technical Education

Publisher

Elsevier BV

Reference53 articles.

1. Breast cancer statistics, 2022;Giaquinto;Ca - Cancer J. Clin.,2022

2. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function;Massarweh;Cancer Res.,2008

3. Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer;Shou;J. Natl. Cancer Inst.,2004

4. NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer;Yuan;Ther. Adv. Med. Oncol.,2021

5. Resistance to trastuzumab in breast cancer;Pohlmann;Clin. Cancer Res.,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP